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Estimation of daily risk of neonatal death, including the day 
of birth, in 186 countries in 2013: a vital-registration and 
modelling-based study
Shefali Oza, Simon N Cousens, Joy E Lawn
Summary 
Background The days immediately after birth are the most risky for human survival, yet neonatal mortality risks are 
generally not reported by day. Early neonatal deaths are sometimes under-reported or might be misclassiﬁ ed by day of 
death or as stillbirths. We modelled daily neonatal mortality risk and estimated the proportion of deaths on the day of 
birth and in week 1 for 186 countries in 2013.
Methods We reviewed data from vital registration (VR) and demographic and health surveys for information on the 
timing of neonatal deaths. For countries with high-quality VR we used the data as reported. For countries without 
high-quality VR data, we applied an exponential model to data from 206 surveys in 79 countries (n=50 396 deaths) to 
estimate the proportions of neonatal deaths per day and used bootstrap sampling to develop uncertainty estimates.
Findings 57 countries (n=122 757 deaths) had high-quality VR, and modelled data were used for 129 countries. The 
proportion of deaths on the day of birth (day 0) and within week 1 varied little by neonatal mortality rate, income, or 
region. 1·00 million (36.3%) of all neonatal deaths occurred on day 0 (uncertainty range 0·94 million to 1·05 million), 
and 2·02 million (73.2%) in the ﬁ rst week (uncertainty range 1·99 million to 2·05 million). Sub-Saharan Africa had 
the highest risk of neonatal death and, therefore, had the highest risk of death on day 0 (11·2 per 1000 livebirths); the 
highest number of deaths on day 0 was seen in southern Asia (n=392 300).
Interpretation The risk of early neonatal death is very high across a range of countries and contexts. Cost-eﬀ ective and 
feasible interventions to improve neonatal and maternity care could save many lives.
Funding Save the Children’s Saving Newborn Lives programme.
Copyright © Oza et al. Open Access article distributed under the terms of CC BY.
Introduction
Birth and the following few days are biologically and 
emotionally remarkable, but are also the riskiest for 
survival. The Millennium Development Goals (MDGs) 
have galvanised eﬀ orts to substantially reduce maternal 
and child mortality, yet deaths in the neonatal period (the 
ﬁ rst 4 weeks after birth) have decreased more slowly.1,2 
The estimated average annual rate of mortality reduction 
for neonates was 2·2% from 1990 to 2013,3 compared 
with 4·0% for children aged 1–59 months3 and 2·6% for 
maternal deaths.4 The risk of death in the ﬁ rst days after 
birth is strikingly high. In 2013, 2·8 million (44%) of the 
6·3 million deaths in children younger than 5 years 
occurred during the neonatal period,3 along with an 
estimated 1·2 million intrapartum stillbirths.5 Around 
three-quarters of neonatal deaths are estimated to occur 
during the ﬁ rst week of life.6,7
Deaths on the day of birth (day 0) are particularly 
important to assess because they account for a large 
number of deaths that can be targeted by interventions 
at birth. Risk of death falls substantially even within 
hours of birth: risk in the ﬁ rst hour after birth in the 
USA is 0·91 per 1000 livebirths,8 but in the following 
23 h is 1·58 per 1000 livebirths, which translates to a 
much lower average hourly risk of about 0·07. The 
causes of death shortly after birth are similar to those of 
intrapartum stillbirths and change later in the neonatal 
period. This similarity has led to the proposal of an 
indicator that combines intrapartum deaths and those 
on the day of birth as a marker of the quality of 
intrapartum care.9 Yet no systematic, nationally 
comparable estimates of risk during the ﬁ rst day of life 
are reported, despite increasing programmatic focus on 
this important time period.
Vital-registration (VR) data, which are collected from 
birth and death certiﬁ cates, are available for more than 
half of the 193 UN member states,10 but only about half of 
those datasets (generally from the wealthiest nations) are 
reliable, and account for fewer than 5% of neonatal 
deaths worldwide.11 For most countries, data by day of the 
neonatal period are either unavailable or are derived 
from cross-sectional surveys,12 which ask women of 
reproductive age how many of their children have died 
and the child’s age at death. These data are susceptible to 
error, with possible under-reporting of deaths, including 
stillbirths, and misreporting of the day of death.13–15 Of 
particular importance for this study is the potential for 
misrecording of deaths (day 1 instead of day 0) and 
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misclassiﬁ cation of deaths as stillbirths rather than very 
early neonatal deaths (panel 1).
To provide estimates for countries without VR data of 
adequate quality, modelling remains necessary. Estimates 
of mortality in children younger than 5 years, including 
neonatal mortality, are regularly published per country 
by the UN and the Institute for Health Metrics and 
Evaluation.3,11,18,19 Nevertheless, multicountry analyses of 
the daily risk of death within the neonatal period do not 
seem to be available. Standard life tables and survival 
curves generally group data into time periods of months 
or years rather than days.20 Although the information on 
the modelling of survival curves within the neonatal 
period is sparse, some work suggests that exponential 
functions are suitable for modelling mortality risk in the 
neonatal period and that other functions, such as the 
Gompertz or Weibull functions, are better for later 
periods in the lifespan.21,22 Exponential functions have 
been used to counteract the propensity for reporting 
deaths on certain days, for instance at 
1 week (termed heaping).13
Analyses of survey data have suggested that up to 50% 
of neonatal deaths occur in the ﬁ rst 24–48 h after birth 
but highlighted data limitations, including the 
misclassiﬁ cation of deaths on day 0 as being on day 1 and 
heaping of death reports on particular days.6
We used VR data and applied a mathematical model to 
survey data to estimate risks and numbers of neonatal 
deaths for the day of birth, in the ﬁ rst week of life, and in 
the late neonatal period for 186 countries in 2013.
Methods
Selection of data
Eligible data were WHO VR data or data derived from 
MEASURE demographic and health surveys (DHS) 
(appendix). We reviewed the latest publicly available 
WHO VR data from the years 2006–10, except for Canada, 
for which the data from Statistics Canada were used 
because they were more recent. DHS data from 1986 to 
2011 were acquired with the STATcompiler tool from 
MEASURE DHS. Finally, to estimate risk of death and 
numbers of deaths by time period, we applied our results 
to the 2013 estimates of neonatal deaths and livebirths 
produced by the UN Inter-agency Group for Child 
Mortality Estimation.3
We used the VR data to generate national risk estimates 
if the country had VR coverage of adult mortality of at 
least 80%10 and the data on neonatal deaths were 
categorised in the time periods day 0, days 1–6, and 
days 7–27 (appendix), which is the most detailed 
breakdown of data that WHO provides. For countries 
with more than 50 neonatal deaths recorded in the latest 
year with available data, we used those data. For 
countries with fewer than 50 neonatal deaths in the 
latest year with available data, we combined deaths from 
the previous 2–5 years until the total number of neonatal 
deaths was at least 50, to avoid instability because of 
small numbers. We took reports of 20% or less of deaths 
occurring on day 0 or no deaths occurring on days 1–6 to 
indicate poor data quality and excluded data from these 
countries (appendix).
Statistical analysis
All statistical analyses were done with Stata (version 12). 
For countries without adequate VR data we postulated a 
three-parameter model for the daily risk of neonatal 
death that we applied to the DHS data to estimate the 
proportion of deaths occurring on each day of the 
neonatal period. The model assumed that the probability 
of dying on day t, conditional on surviving until that day, 
declines exponentially. Additionally, the model allowed 
the probability of dying on day 0 to diﬀ er from this 
pattern. Mathematically, this can be expressed as:
where ht is the probability of dying on day t conditional 
on survival until that day. The unconditional probability 
of dying on day t of the neonatal period, pt, can be derived 
from the multinomial distribution (appendix). The 
likelihood of observing n0, …, n27 deaths in the neonatal 
period conditional on N livebirths, and the proportion 
surviving the neonatal period, ps, can be expressed as:
See Online for appendix
For MEASURE DHS see http://
www.measuredhs.com/
ht=
α
βγ t–1
t=0
1 ≤ t ≤ 27
Equation 1:
Panel 1: Challenges to the measurement of neonatal death
Time periods 
The neonatal period refers to the ﬁ rst 28 days of life. The early neonatal period is the ﬁ rst 
7 days and the late neonatal period the remaining 21 days. The ﬁ rst day of life is typically 
called day 0 in survey and vital-registration data or day 1 in clinical practice (ie, from days 
0–27 or days 1–28 for the full neonatal period). In this Article we use the neonatal periods 
day 0 for the ﬁ rst day of life, days 0–6 for the early neonatal period, days 7–27  for the late 
neonatal period, and days 0–27 for the full neonatal period.   
Misclassiﬁ cation between stillbirths and livebirths
The probability of recording the baby as being alive at birth is associated with the 
perception of viability of survival. For example, if babies are not assessed at birth and 
resuscitated, a live baby born at term that is not breathing might be misclassiﬁ ed as a 
stillbirth.5,16 Misclassiﬁ cation of livebirths and stillbirths is most common in this direction.
Variation of registration with gestational age
As complexity of care increases and even very preterm babies before 25 weeks of 
gestation are given intensive care, the registration of livebirths at less than 28 weeks 
increases, as documented in Denmark.17 Some countries without care for extremely 
preterm babies still might not count some of these babies as livebirths.
Classiﬁ cation of day of death
The perception of what time period comprises the ﬁ rst day of life can lead to important 
diﬀ erences in recording practices. Diﬀ erent ways in which the end of the ﬁ rst day of life is 
indicated include the ﬁ rst 24 h after birth, until sundown of the day of birth, or the change 
in calendar date. These variations can lead to diﬀ erences in the recording of whether 
death occurred on day 0 or day 1 in surveys, dependent on respondents’ and interviewers’ 
understanding, which can aﬀ ect interpretation of survey results.
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To deal with potential misclassiﬁ cation between days 0 
and 1 in the DHS data, we combined observed deaths on 
days 0 and 1 and rewrote the likelihood calculation as:
We used maximum likelihood to estimate the 
parameters α, β, and γ (appendix). This model allowed 
us to estimate a corrected proportion of neonatal deaths 
on day 0 under the assumption encoded in the model 
that the probability of dying on subsequent days 
declines. With use of these estimates, we calculated the 
expected proportion of neonatal deaths on a given day 
(appendix) and during the time periods days 1–6, 
days 7–27, and week 1 (days 0–6). We initially applied 
the model to the aggregated DHS data, followed by 
ﬁ tting the model to subsets of the data (neonatal 
mortality rates, national income category and 
geographic region [appendix], and survey period) to 
investigate whether these aﬀ ected the proportional 
distribution of deaths.
We compared our postulated model with a simpler 
two-parameter model that assumes γ=1, by use of a 
likelihood ratio test (appendix). To enable us to correct 
for misreporting between days 0 and 1, we ﬁ tted a model 
in which the relation between day 1 deaths and those on 
subsequent days was constrained. 
We calculated the proportions of deaths on day 0 and 
in week 1 directly from the VR data for countries with 
high-quality VR data, and from our DHS-based model 
for the countries with inadequate VR data. We excluded 
countries with fewer than 1000 livebirths. We calculated 
the number of deaths by applying the day 0 and in 
week 1 proportions to the UN Inter-agency Group for 
Child Mortality Estimation 2013 neonatal death 
estimates. We then derived the risk values for day 0, 
week 1, and days 7–27 by dividing the time-period-
speciﬁ c mortality values by the number of livebirths in 
the country in 2013.
We developed uncertainty estimates for the modelled 
proportions by drawing 1000 bootstrap samples with 
replacement from the 206 DHS in the input dataset. We 
reran the analysis to estimate the model parameters and 
used these to estimate the proportion of deaths by day for 
each of the 1000 datasets. Finally, we took centiles 2·5 
and 97·5 from the resulting distributions of these 
proportions as the boundaries of uncertainty. Our 
uncertainty estimates do not include uncertainty in the 
total number of neonatal deaths. For countries with 
adequate VR data, we calculated the uncertainty for the 
proportions by assuming a Poisson distribution for the 
number of deaths during those periods (ie, the SE is 
equal to the square root of the reported number of 
deaths). Finally, we did validation exercises, including 
out-of-sample validation and the addition of VR data to 
the model (appendix).
Figure 1: Analysis strategy
VR=vital registration. DHS=demographic and health surveys. IGME=Inter-agency group for Child Mortality 
Estimation.
VR data (109 countries) DHS data (206 surveys, 79 countries)
DHS data ﬁtted with mathematical function; 
maximum likelihood for parameter estimates
Proportions by country and time period 
directly from VR data
Proportions by neonatal time period 
derived from curve ﬁt
Bootstrap estimation method
52 excluded
24 <80% VR coverage
14 no day of birth breakdown
13 <20% deaths on day of birth
1 with no deaths from
days 1 to 6
57 countries, 122 757 deaths 206 surveys (79 countries, 50 396 deaths)
Number of deaths and risk: apply proportions of IGME neonatal deaths and livebirths for 2013
Data input
Exclusions
Curve fit
Final input
Outputs
Estimates Assume Poisson (SE=square root of 
number of deaths)
57 countries, 0·1 million neonatal deaths 
in 2013
129 countries, 2·7 million neonatal deaths 
in 2013
Figure 2: Proportions of neonatal deaths for 57 countries with vital-
registration data on days 0, 1–6, and 7–27
Horizontal lines=median. Boxes=IQR. Vertical lines=upper and lower adjacent 
values. Circles=outliers. 
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Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
Results
Of 109 countries with VR data, 52 were excluded (ﬁ gure 1, 
appendix). Among the 57 countries with high-quality VR 
data, seven reported fewer than 50 neonatal deaths in the 
latest year of available data. Of the 206 DHS, 15 reported 
fewer than 50 neonatal deaths, but we did not exclude 
these because deaths from all surveys were combined in 
our mathematical model. After exclusions, therefore, the 
input dataset comprised 57 countries with adequate VR 
data (median reporting year 2010) on 122 757 neonatal 
deaths and 206 DHS (median reporting year 1999) from 
79 countries reporting on 50 396 neonatal deaths in the 
previous 5 years. Nine countries had VR and DHS data. 
Thus, the ﬁ nal input dataset contained information from 
127 countries and included data on 173 153 neonatal deaths.
For countries with adequate VR data, the median 
proportions of neonatal deaths, by neonatal time period, 
were as follows: 0·35 (IQR 0·29–0·46) on day 0; 0·36 
(0·32–0·42) on days 1–6; and 0·25 (0·22–0·30) on 
days 7–27 (ﬁ gure 2). The median proportion of deaths in 
week 1 was 0·75 (IQR 0·70–0·78). The proportion of 
deaths across countries on day 0 varied more than for the 
other time periods. The three countries with the highest 
proportions of deaths on day 0 were Switzerland (0·71 
[SD 0·04]), Canada (0·69 [0·02]), and Austria (0·62 
[0·07]), and the three with the lowest proportions were 
the Czech Republic (0·23 [0·06]), Belize (0·24 [0·10]), 
and Macedonia (0·25 [0·07]).
Of the 79 countries with DHS data, 29 had one survey 
and the remaining 50 had between two and six surveys 
each. Across all surveys, the median proportion of 
reported deaths was 0·26 (IQR 0·19–0·32) on day 0, 0·19 
(0·15–0·24) on day 1, 0·46 (0·40–0·52) on days 1–6 
(ﬁ gure 3), and for week 1 was 0·72 (0·68–0·78). The 
median proportion for days 0 and 1 combined was 
0·46 (IQR 0·39–0·52). 66 (32%) DHS datasets had 
higher proportions of deaths on day 1 than day 0, which 
suggests substantial misclassiﬁ cation of deaths between 
these days. For surveys with higher proportions of deaths 
on day 0 than day 1, the median proportion of reported 
deaths by time period was 0·29 (IQR 0·25–0·35) on 
day 0, 0·16 (0·13–0·21) on day 1, 0·43 (0·39–0·48) for 
days 1–6 (ﬁ gure 3), and for week 1 was 0·73 (0·69–0·78). 
Figure  4 shows a comparison of the reported proportion 
of deaths on day 0 in the VR and DHS data with neonatal 
mortality rates and identiﬁ es DHS data with severe 
(number of day 0 deaths less than or equal to the number 
of day 1 deaths) under-reporting, misrecording, or both, 
of day 0 deaths. Even DHS with higher day 0 than day 1 
deaths might have some misclassiﬁ cation. The only 
discernible pattern is that several countries with high-
quality VR data and very low neonatal mortality rates 
(fewer than ﬁ ve deaths per 1000 livebirthds) had high 
reported proportions of deaths on day 0 deaths.
Figure 4: Proportion of reported deaths on day 0 for national VR datasets and DHS datasets organised by NMR
DHS=demographic and health survey. VR=vital registration. NMR=neonatal mortality rate.  
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Figure 3: Proportions of neonatal deaths on day 0, days 1–6, and 7–27 
derived from DHS
DHS=demographic and health surveys. Horizontal lines=median. Boxes=IQR. 
Vertical lines=upper and lower adjacent values. Circles=outliers.
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Our three-parameter model ﬁ tted the observed DHS 
data better than the two-parameter model (p<0·0001). 
Visual inspection of the modelled versus the observed 
distribution of deaths by day in the DHS data also 
indicated a good ﬁ t (ﬁ gure 5). The poorest ﬁ t was seen on 
days 7, 14, and 15, which probably reﬂ ects the propensity 
to report deaths at 1 and 2 weeks (ﬁ gure 5). The estimated 
parameter values from equation 1 were α=0·012 
(uncertainty range 0·010–0·014), β=0·003 (0·002–0·003), 
and γ=0·872 (0·868–0·875).
The modelled proportions for deaths during the 
neonatal period were 0·36 (uncertainty range 0·34–0·38) 
on day 0 and 0·73 (0·72–0·74) for week 1. These estimates 
are similar to the median proportions seen in the VR 
data (0·35 for day 0 and 0·75 for week 1). Without 
correction for misclassiﬁ cation between day 0 and day 1 
(ie, running the model with data for these days separated), 
the estimated proportions for the DHS data are 0·26 
(uncertainty range 0·24–0·27) for day 0 and 0·73 
(0·72–0·74) for days 0–6 (full daily proportion 
results are presented in the appendix). The out-of-sample 
validation analysis suggested good overall agreement 
between the observed and modelled results across 
surveys, and the inclusion of VR data in the model 
yielded similar results to DHS data alone (appendix).
The estimated proportion of deaths on day 0 did not 
vary importantly when assessed by neonatal mortality 
rate or income (table 1, ﬁ gure 6). Some variation was 
seen between regions and survey timings (table 1, 
ﬁ gure 6). We combined the 28 datasets from the northern 
Africa, western Asia, and Caucasus and central Asia 
Millennium Development Goals regions to form a mid-
east region for our DHS analysis to avoid small numbers 
and because of similarities in the data and health 
systems. 21 (75%) of 28 DHS from this mid-east region 
reported fewer deaths on day 0 than on day 1, which 
suggests widespread undercounting of day 0 deaths, 
misreporting of day 0 deaths as day 1 deaths, or both. By 
comparison, ten (26%) of 38 DHS reported more day 1 
than day 0 deaths in the Latin America and Caribbean 
region, which had the next highest percentage of surveys, 
reported with these issues. The estimated proportions of 
day 0 deaths did not diﬀ er substantially between the 
other regions. When we excluded the mid-east region 
from the analysis, the overall results remained largely 
unchanged (proportion of deaths 0·36 [uncertainty range 
0·35–0·38] for day 0 and 0·73 [0·72–0·74] for week 1). 
For survey period, earlier surveys had, on average, lower 
proportions of deaths in the ﬁ rst few days than did later 
surveys. When we assessed only surveys done in 2000 or 
later, the proportions of day 0 and week 1 deaths were 
0·39 (uncertainty range 0·37–0·41) and 0·75 (0·73–0·76).
In theory, our model requires the total number of 
livebirths to be known as well as the numbers of neonatal 
deaths per day. We found, however, that varying the 
number of livebirths while keeping the number of deaths 
ﬁ xed across a wide range of neonatal mortality rates 
(from 1 to 1000) resulted in negligible changes (<0·5 
percentage points) to the estimated day 0 and week 1 
proportions of deaths. Thus, in practice, the results do 
not appear to be sensitive to the number of livebirths.
Around 2·76 million neonatal deaths occurred in the 
186 countries in this anaylsis.3 Of these, an estimated 
1·00 million (36·3%) occurred on day 0 (uncertainty 
range 0·94–1·05 million) and 2·02 million (73·2%) 
occurred within week 1 (1·99–2·05 million).
Of the Millennium Development Goals regions, sub-
Saharan Africa had the highest risk of deaths per 1000 
livebirths on day 0 and in week 1 (table 2). The risk of 
death for Southern Asia was slightly lower, but this 
region had the largest number of births and, therefore, 
Figure 5: Observed and modelled mortality during the neonatal period
(A) Observed and modelled cumulative mortality curves. The combined proportion of day 0 and day 1 deaths is 
about 0·45 in the observed data and modelled estimates. (B) Daily proportions with 95% CIs. DHS=demographic 
and health survey.
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the largest number of deaths (table 2). Figure 7 shows the 
risk of death on the day 0 and during the neonatal period, 
alongside perterm brith rates, for 31 industrialised 
countries with high-quality VR data. In the USA and 
Canada, the risk of death on day 0 was 2·4 and 2·3 per 
1000 livebirths, respectively, whereas in several northern 
European countries (eg, Norway, Sweden, and Finland) 
the risk was 0·6 or lower (ﬁ gure 7).
Full results for the 186 countries are available in the 
appendix. The risk of death per 1000 livebirths ranged 
widely across countries in all time periods (table 3, 
appendix). Nine of the ten countries with the highest risk 
were in sub-Saharan Africa. The risk of death for these 
ten countries ranged from 14 to 17 per 1000 livebirths on 
day 0 and from 29 to 34 per 1000 livebirths in week 1 
(table 3). The number of deaths during each time period 
also varied widely. The ten countries with the highest 
numbers of deaths (range 14 300–270 100 on day 0 and 
28 900–546 300 in week 1, table 4) were all populous but 
were also aﬀ ected by the level of risk.
Discussion
We estimated the risk of dying and numbers of deaths for 
the day of birth, ﬁ rst week of life, and the late neonatal 
period in 2013 for 186 countries in follow-up to our 
preliminary results.24 Of the 2·76 million neonatal deaths 
worldwide, an estimated 36·3% of deaths occurred on the 
day of birth and 73·2% within week 1. Hence, around 
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Figure 6: Observed and modelled cumulative mortality during the neonatal period by NMR, income, region, and survey period
Data are for 206 demographic and health surveys (n=50 396 neonatal deaths) from 1986 to 2011. NMR=neonatal mortality rate.
Day 0 (uncertainty 
range)
Week 1 (uncertainty 
range)
Neonatal mortality rate
≥5–<15 0·34 (0·31–0·38) 0·72 (0·71–0·74)
≥15–<30 0·37 (0·35–0·39) 0·73 (0·71–0·74)
≥30 0·36 (0·33–0·38) 0·74 (0·72–0·76)
Income
Low 0·36 (0·34–0·39) 0·73 (0·72–0·74)
Lower-middle 0·36 (0·33–0·38) 0·73 (0·72–0·74)
Upper-middle 0·38 (0·35–0·41) 0·73 (0·70–0·75)
Region
East Asia and southeast 
Asia
0·39 (0·33–0·43) 0·74 (0·72–0·78)
Southern Asia 0·36 (0·33–0·39) 0·73 (0·71–0·75)
Sub-Saharan Africa 0·37 (0·34–0·39) 0·74 (0·72–0·75)
Latin America and the 
Caribbean
0·39 (0·36–0·42) 0·72 (0·70–0·74)
Northern Africa, western 
Asia, and Caucasus and 
central Asia
0·28 (0·25–0·32) 0·70 (0·68–0·71)
Survey period
1986–95 0·32 (0·30–0·35) 0·71 (0·69–0·73)
1996–2005 0·37 (0·35–0·39) 0·73 (0·72–0·75)
2006–11 0·41 (0·37–0·43) 0·76 (0·73–0·78)
Overall 0·36 (0·34–0·38) 0·73 (0·72–0·74)
Table 1: Estimated proportions of deaths on day 0 and in week 1, by 
subgroup
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1·0 million babies die on the day of birth, and these 
deaths are in addition to the 1·2 million intrapartum 
stillbirths that occur each year. This observation highlights 
the fact that the hours just before birth and the ﬁ rst few 
days of life are the most risky in the human lifespan. The 
risk for mothers is also increased during this period.2
For countries without high-quality VR data, we 
estimated the proportional distribution of neonatal 
deaths by day by aggregating DHS data from countries 
with a range of neonatal mortality rates. The parameter 
estimates we obtained (α, β, and γ), therefore, represent 
average values, which we used to estimate the average 
distribution of deaths by day. We examined whether 
application of this average distribution to countries with 
diﬀ erent neonatal mortality rates was appropriate by 
ﬁ tting the model to subsets of data. The proportion of 
deaths on day 0 was consistent across countries with 
diﬀ erent neonatal mortality rates and incomes. The 
proportions of day 0 deaths varied a little by region, but 
might reﬂ ect under-reporting or misclassiﬁ cation. The 
proportion of day 0 deaths also varied slightly between 
earlier and later surveys, with the proportion of day 0 
deaths being lower in the former. We chose, however, to 
include all survey years in our model because whether 
there was a real change in proportions over time is 
unclear. Another multicountry study found that 
enumeration of child deaths was poorer in later than in 
earlier surveys within countries.25 We also found that 
several countries with multiple surveys had wide 
ﬂ uctuations in the proportions of deaths on day 0 that 
were not in a consistently upward direction. Since the 
proportion of day 0 deaths was slightly higher when the 
analysis was restricted to the surveys done in 2000 or 
later, we chose a conservative approach to estimating 
proportions of deaths on day 0.
Figure 7: Risk of death on the day of birth and during the neonatal period in 2013 for 31 industrialised 
countries with high-quality vital registration data, with 2010 preterm rates23
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Risk (uncertainty 
range)*
Deaths (uncertainty 
range)*
Risk 
(uncertainty 
range)*
Deaths (uncertainty 
range)*
Sub-Saharan Africa 11·2 (10·6–11·8) 385·2 (362·6–404·9) 22·7 (22·4–23·0) 779·1 (767·5– -788·9) 8·4 (8·1–8·7) 286·2 (276·6–297·8)
Southern Asia 10·6 (10·0–11·2) 392·3 (369·1–412·5) 21·5 (21·2– -21·8) 793·3 (781·5– -803·3) 7·9 (7·7–8·2) 292·0 (282·2–303·9)
Oceania 7·7 (7·3–8·1) 2·0 (1·9–2·1) 15·6 (15·4–15·8) 4·1 (4·1–4·2) 5·7 (5·6–6·0) 1·5 (1·5–1·6)
Caucasus and 
central Asia
5·4 (5·1–5·7) 9·5 (8·9–10·0) 11·0 (10·8–11·2) 19·2 (18·8–19·5) 3·8 (3·6–3·9) 6·6 (6·3–6·9)
Southeastern Asia 5·2 (4·9–5·5) 58·0 (54·5–60·9) 10·5 (10·4–10·6) 117·2 (115·5–118·7) 3·9 (3·7–4·0) 43·1 (41·7–44·9)
Western Asia 4·9 (4·6–5·2) 24·0 (22·6–25·3) 10·0 (9·8–10·1) 48·6 (47·9–49·3) 3·7 (3·6–3·8) 18·0 (17·3–18·7)
Northern Africa 4·8 (4·5–5·1) 19·3 (18·1–20·3) 9·7 (9·6–9·8) 39·0 (38·4–39·5) 3·6 (3·5–3·7) 14·3 (13·9–14·9)
Latin America and 
the Caribbean
3·2 (3·1–3·4) 35·4 (33·8–36·9) 6·8 (6·7–7·0) 74·3 (72·7–75·9) 2·4 (2·3–2·5) 26·2 (25·1–27·3)
Eastern Asia 2·8 (2·6–2·9) 54·3 (51·1–57·1) 5·6 (5·5–5·7) 109·8 (108·2–111·2) 2·1 (2·0–2·2) 40·4 (39·1–42·1)
Developed regions 1·6 (1·5–1·7) 22·9 (21·6–24·2) 2·6 (2·5–2·7) 36·6 (35·2–38·1) 0·8 (0·7–0·9) 11·5 (10·6–12·4)
World 7·3 (6·9–7·6) 1002·7 (944·2– 1054·1) 14·7 (14·4–14·9) 2021·3 (1989·7–2048·5) 5·4 (5·2–5·6) 739·8 (714·3–770·6)
*Uncertainty estimates do not include uncertainty in total neonatal deaths.
Table 2: Risk of death per 1000 livebirths and numbers of deaths (in thousands) in 2013, by Millennium Development Goals region and neonatal time period
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We noted variation in the proportion of day 0 deaths for 
some countries with very low neonatal mortality rates 
(fewer than ﬁ ve per 1000 livebirths, ﬁ gure 4). Since the 
availability of good neotnatal intensive care should avert 
most later deaths due to infection, countries with 
comprehensive neonatal intensive care provision might 
be expected to have higher proportions of neonatal deaths 
on day 0 and in week 1.23,26 An eﬀ ect of neonatal intensive 
care, however, is to shift day 0 deaths to later days, for 
example because preterm babies are saved by early 
intervention but die later from complications, such as 
intracranial haemorrhage or infection. Thus, while the 
overall risk might be lower, the proportion of deaths could 
remain similar owing to deaths occurring later in (or even 
beyond) the neonatal period.
Although the risk of death on day 0 was 30 times greater 
in the poorest countries than in the richest, there was also 
a surprising almost ten times diﬀ erence in day 0 risk 
across the richest countries. In view of the high quality of 
data collection and intensive care in these countries, this 
variation is probably real and not an artifact of under-
reporting. The high preterm birth rate in North America 
might explain the relatively high proportion of day 0 
deaths there, especially in the USA, where more than 
500 000 (12%) of all births are preterm each year.17
The exponential function we used ﬁ tted the DHS data 
well. We applied the modelled estimates to countries 
with no day-of-death data, and to those with DHS data 
because substantial bias from misclassiﬁ cations of day 0 
and day 1 deaths was evident in some DHS. A third of 
DHS reported more deaths on day 1 than day 0, which is 
biologically implausible. In countries that had VR and 
DHS data (and more than 50 neonatal deaths), no DHS 
that reported more day 1 than day 0 deaths was supported 
by the VR data. In surveys with more day 0 than day 1 
deaths, some deaths being misrecorded as day 1 is 
possible, but would be more diﬃ  cult to identify. We tried 
to correct for this type of error by using our mathematical 
model on the combined surveys. We did not, however, 
account for misclassiﬁ cations of stillbirths and early 
neonatal deaths, which is another well recognised issue 
in DHS.27 If neonatal deaths in the ﬁ rst minutes of life 
are recorded as stillbirths (which is the most common 
direction of misclassiﬁ cation), very early neonatal deaths 
will be undercounted, and we would expect the 
proportion of deaths during week 1 to be lower than 
average irrespective of day 0 and day 1 misclassiﬁ cation.
For 19 (9·2%) of the 206 DHS, the proportions of deaths 
in week 1 had uncertainty values that fell outside our 
boundaries (centiles 2·5 and 97·5). Of these surveys, seven 
reported more day 1 than day 0 deaths. The remaining 
12 all had low proportions of neonatal deaths for week 1 
compared with the other 194 surveys (median proportion 
0·60, IQR 0·56–0·63 vs 0·73, 0·69–0·78). This pattern is 
consistent with undercounting of early neonatal deaths.
Finally, several countries with multiple DHS had 
ﬂ uctuations in proportions of day 0 and week 1 deaths 
that are unlikely to be explained by real changes. For 
example, the day 0 proportion of deaths in Ethiopia varied 
from 0·30 in 2000, to 0·19 in 2005, to 0·42 in 2011. 
Because of potential poor-quality data and random errors 
within individual surveys, we chose to apply our model to 
DHS data overall to predict day 0 and week 1 proportions 
of neonatal deaths instead of using the raw DHS data. We 
also developed simple analytical methods to identify DHS 
with misclassiﬁ cations and under-reporting (appendix).
We hope that our estimates will be improved on as 
better data become available. While our DHS-based model 
seems robust, it is not ideal to apply this one model to all 
countries without adequate VR data. We believe that, on 
average, our results adequately represent the day 0 and 
week 1 proportions for many of the modelled countries, 
but this approach masks variation between countries. 
Since the same proportions for day 0 and week 1 were 
applied to all countries with inadequate VR data, the 
rankings are tied to variation in neonatal mortality rates 
and the total number of neonatal deaths per country. Also, 
our uncertainty ranges do not reﬂ ect the uncertainty in 
Day 0 Week 1 Weeks 2–4
India 270·1 (254·1–284·0) 546·3 (538·2–553·1) 201·1 (194·3–209·3)
Nigeria 94·4 (88·8–99·3) 191·0 (188·1–193·4) 70·3 (67·9–73·2)
Pakistan 70·0 (65·9–73·6) 141·6 (139·5–143·3) 52·1 (50·4–54·2)
China 51·8 (48·7–54·4) 104·7 (103·1–106·0) 38·5 (37·2–40·1)
Democratic Republic of the Congo 37·8 (35·6–39·7) 76·4 (75·3–77·4) 28·1 (27·2–29·3)
Ethiopia 30·5 (28·7–32·1) 61·7 (60·8–62·4) 22·7 (21·9–23·6)
Bangladesh 27·7 (26·1–29·2) 56·1 (55·2–56·8) 20·6 (19·9–21·5)
Indonesia 23·8 (22·4–25·0) 48·1 (47·4–48·7) 17·7 (17·1–18·4)
Angola 15·4 (14·5–16·2) 31·1 (30·7–31·5) 11·5 (11·1–11·9)
Kenya 14·3 (13·4–15·0) 28·9 (28·5–29·3) 10·6 (10·3–11·1)
Total† 649·7 (611·3–683·2) 1314·0 (1294·5–1330·5) 483·7 (467·5–503·4)
*Uncertainty estimates do not include uncertainty in total neonatal deaths. †Based on rounded estimates.
Table 4: Number of deaths in thousands (uncertainty range)* in diﬀ erent neonatal time periods for the 
ten countries with the most neonatal deaths in 2013
Day 0 Week 1 Weeks 2–4
Angola 17 (16–18) 34 (34–34) 13 (12–13)
Somalia 17 (16–18) 34 (33–34) 12 (12–13)
Sierra Leone 16 (15–17) 32 (32–33) 12 (12–12)
Guinea-Bissau 16 (15–17) 32 (32–33) 12 (11–12)
Lesotho 16 (15–17) 32 (31–32) 12 (11–12)
Central African Republic 16 (15–16) 31 (31–32) 12 (11–12)
Pakistan 15 (14–16) 31 (30–31) 11 (11–12)
Mali 15 (14–15) 29 (29–30) 11 (10–11)
Chad 14 (14–15) 29 (29–29) 11 (10–11)
Zimbabwe 14 (13–15) 29 (28–29) 11 (10–11)
*Uncertainty estimates do not include uncertainty in total neonatal deaths.
Table 3: Risk of death per 1000 livebirths (uncertainty range)* in 
diﬀ erent neonatal time periods for the ten countries with the highest 
risks in 2013
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neonatal mortality rates because this information was 
unavailable for the most recent estimates. Thus, as with 
all modelled estimates, our results represent a starting 
point for understanding the burden of deaths on day 0 
and in week 1 of the neonatal period in each country.
If relevant high-quality VR data were available for 
individual days, we would be able to compare our DHS-
based model against these survival curves and test more 
complex models. For example, because we attempted to 
correct for misclassiﬁ cation of deaths between days 0 and 
1, we assumed that from day 1 onwards the daily hazard 
declines exponentially. Our model seemed to ﬁ t the data 
well, but high-quality day-of-death data would be required 
for external validation. Currently, the VR data available 
through WHO are limited to the three time periods, 
day 0, days 1–6, and days 7–27 and, therefore, cannot be 
used to construct neonatal survival curves. Additionally, 
some characteristics, such as income and neonatal 
mortality rate, diﬀ er substantially for countries with 
high-quality VR and those requiring modelled estimates, 
thus making a comparison with existing data is diﬃ  cult.
Another desirable improvement would be subnational 
estimates, particularly for countries with decentralised 
systems and high variability, such as India and Nigeria. 
Subnational estimates are seldom available even for 
countries with adequate national VR data, but are 
important for priority setting and sharing lessons within 
and between health systems. For example, the risk of 
death at day 0 per 1000 livebirths in the USA ranged 
from 1·3 in Alaska to 4·8 in the District of Columbia for 
the years 2007–10.8 The county-level diﬀ erences were 
even wider, from a risk of 0·9 in Hidalgo County, TX, to 
6·2 in Baltimore City, MD.8 Additionally, a few studies 
have assessed diﬀ erences in the distributions of causes 
of neonatal death by day. Striking diﬀ erences were found 
not only between deaths in the early and late neonatal 
periods but also between those on day 0 and on later 
days.28,29 Improved understanding of the causal 
distribution of neonatal deaths by day is needed to 
improve care, but no systematic nationally comparable 
estimates yet exist. Finally, we did not assess sex-speciﬁ c 
risks during the neonatal period, but this feature will be 
important to assess in future work.
In the coming years we need to accelerate the 
impressive progress being made in reducing preventable 
child deaths, including the burden of nearly 3 million 
neonatal deaths that are most frequent within the ﬁ rst 
week of life (panel 2). Eﬀ ective and low-cost 
interventions exist but are not accessible to every 
woman and neonate, especially around the time of birth 
when both groups are most vulnerable to death and 
long-term disability.2 Four simple and cost-eﬀ ective 
interventions—steroid injections for women in preterm 
labour, resuscitation devices, chlorhexidine cord 
cleansing, and injectable antibiotics—could save the 
lives of up to 1 million neonates per year.24 Improved 
obstetric services and neonatal care linked to 
community-based programmes in low-income and 
middle-income countries30,31 could prevent almost all 
these deaths and many of the 1·2 million intrapartum 
stillbirths, and 289 000 maternal deaths4 each year.32,33 
The Every Newborn action plan,34 which was endorsed 
at the 2014 World Health Assembly by more than 
190 countries, is an important step towards accelerating 
progress. This plan sets explicit targets of ten or fewer 
neonatal deaths per 1000 livebirths and ten or fewer 
stillbirths per 1000 total births by 2035 for all countries. 
Around the world, a marker of development is when a 
society no longer accepts that stillbirths and neonatal 
deaths are inevitable, that babies can be named at birth 
and counted in national data systems, and that a baby’s 
day of birth should not be his or her last.
Panel 2: Research in context
Systematic review
The risk of dying in the ﬁ rst few days of life is much higher 
than in any other period during the human lifespan. 
Nevertheless, data on deaths by day during the neonatal 
period are not collected in most countries. We searched 
PubMed, Web of Knowledge, and Google Scholar with the 
terms “neonatal”, “newborn”, and one or more of “day of 
birth”, “day 0”, “day 1”, “deaths”, “mortality”, “risk of death by 
day”, “survival”, “survival curves“, “day 0 risk”, “day 1 risk”, 
“temporal distribution”, “day of death”, and “time of death”, 
but found no systematic national estimates of the daily risk 
of death during the neonatal period. We obtained data from 
WHO for countries with civil registration systems. 
57 countries with 122 757 neonatal deaths met our inclusion 
criteria for high-quality vital registration data. We also 
searched for nationally comparable surveys that consistently 
collected information on neonatal deaths by day. We 
identiﬁ ed 206 suitable demographic and health surveys from 
79 countries recording 50 396 neonatal deaths, which we 
used to develop a model that we applied to 129 countries 
without adequate vital-registration data. Hence we produced 
estimates for the risk and number of deaths during the 
neonatal period for 186 countries.
Interpretation
In 2013, 1·00 million (36·3%) of 2·76 million neonatal deaths 
occurred on the day of birth (uncertainty range 0·94 million 
to 1·05 million). In week 1 of life, 2·02 million babies died 
(1·99 million to 2·05 million). Atlhough substantial progress 
has been made in other areas of child health, the neonatal 
period, and particularly the ﬁ rst few days after birth, has been 
relatively neglected. By understanding the tremendously high 
risk of death in the days immediately after birth, policy 
makers and health-care providers can prioritise urgently 
needed interventions. Improved neonatal care linked to 
maternity care will be a crucial step for reducing the risk of 
neonatal mortality. Several simple and cost-eﬀ ective 
interventions exist that can substantially reduce early 
neontatal mortality in even the poorest settings.
For the Every Newborn action 
plan see www.everynewborn.org
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